FREE
Breaking down health care price transparency policies
Please join us this Friday from 10:00-10:30am for a quick virtual briefing on health care price transparency. Please feel free to share this invite with any health care staffer you think would be interested.
Paragon’s Theo Merkel, a key architect of the price transparency rules enacted by the Trump Administration, will outline price transparency policies being considered by Congress. He recently authored a report on the issue for Paragon titled Health Care Price Transparency: Achievements, Challenges, and Next Steps. Paragon President Brian Blase will join Theo in the presentation.
Theo Merkel is the Director of the Private Health Reform Initiative and a Senior Research Fellow for the Paragon Institute and a Senior Fellow at the Manhattan Institute. Previously, Theo served as Special Assistant to the President for Economic Policy at the National Economic Council in the White House (2019-2020). In addition to his work in the executive branch, Theo worked for his home state Senator Pat Toomey for a decade, most recently as Legislative Director.
During his time in the White House, Theo had a wide-ranging portfolio that included Medicare, Medicaid, the commercial market, and drug pricing reform. He oversaw the development and implementation of several key presidential initiatives to improve competition, efficiency, and access in health care including Executive Order 13877, Improving Price and Quality Transparency in American Healthcare to Put Patients First.
Brian Blase, Ph.D. is the President of Paragon Health Institute. Brian was Special Assistant to the President for Economic Policy at the White House’s National Economic Council (NEC) from 2017-2019, where he coordinated the development and execution of numerous health policies and advised the President, NEC director, and senior officials. After leaving the White House, Brian founded Blase Policy Strategies and serves as its CEO.
Brian guided the House Committee on Oversight and Government Reform’s health care and entitlement program oversight and investigation efforts from 2011 to 2014, and then served as the Senate Republican Policy Committee’s health policy analyst from 2014 to 2015.
